Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term chemotherapy. Found 241 abstracts

no pagination
Ozols RF. NICE guidelines for ovarian cancer: Recommendations versus standard care. Cancer Investigation. 2004 Jan;22 (5):815-7.
Rowinsky EK, Schwartz GH, Gollob JA, Thompson JA, Vogelzang NJ, Figlin R, Bukowski R, Haas N, Lockbaum P, Li YP, Arends R, Foon KA, Schwab G, Dutcher J. Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer. Journal of Clinical Oncology. 2004 Aug;22(15):3003-15.
Garcia AA, Bookman MA, Rodriguez-Rodriguez L, Mutch DG, Look KY. Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies - A Gynecologic Oncology Group study. Investigational New Drugs. 2002 Nov;20(4):383-7.
Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: Long-term follow-up of RTOG 92-04. International Journal of Radiation Oncology Biology Physics. 2002 Jul;53(3):548-57.
Wiseman GA, Gordon LI, Multani PS, Witzig TE, Spies S, Bartlett NL, Schilder RJ, Murray JL, Saleh M, Allen RS, Grillo-Lopez AJ, White CA. Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial. Blood. 2002 Jun 15;99(12):4336-42.
Cheng JD, Hitt J, Koczwara B, Schulman KA, Burnett CB, Gaskin DJ, Rowland JH, Meropol NJ. Impact of quality of life on patient expectations regarding phase I clinical trials. Journal of Clinical Oncology. 2000 Jan;18(2):421-8.
Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB, Hanks GE. Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 patterns of care study. Journal of Clinical Oncology. 2000 Feb;18(3):455-62.
Glisson B, Scott C, Komaki R, Movsas B, Wagner H. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: Results of radiation therapy oncology group trial 93-12. Journal of Clinical Oncology. 2000 Aug;18(16):2990-5.
Joseph P, Long DJ, Klein-Szanto AJ, Jaiswal AK. Role of NAD(P)H : quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity. Biochemical pharmacology. 2000 Jul 15;60(2):207-14.
McGuire WP, Blessing JA, Bookman MA, Lentz SS, Dunton CJ. Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group study. Journal of Clinical Oncology. 2000 Mar;18(5):1062-7.
Meek PM, Nail LM, Barsevick A, Schwartz AL, Stephen S, Whitmer K, Beck SL, Jones LS, Walker BL. Psychometric testing of fatigue instruments for use with cancer patients. Nursing research. 2000 Jul;49(4):181-90.
Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. NCCN Practice Guidelines for cancer-related fatigue. Oncology-New York. 2000 Nov;14(11A):151-61.
O'Donnell MR, Appelbaum FR, Baer MR, Carabasi MH, Coutre SE, Erba HP, Estey E, Glenn MJ, Kraut EH, Maslak P, Millenson M, Miller CB, Saba HI, Stone R, Tallman MS. NCCN Practice Guidelines for acute myelogenous leukemia. Oncology-New York. 2000 Nov;14(11A):53-61.
Coia LR, Gunderson LL, Haller D, Hoffman J, Mohiuddin M, Tepper JE, Berkey B, Owen JB, Hanks GE. Outcomes of patients receiving radiation for carcinoma of the rectum - Results of the 1988-1989 patterns of care study. Cancer. 1999 Nov 15;86(10):1952-8.
Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: Patterns of care study. International Journal of Radiation Oncology Biology Physics. 1999 Jan 15;43(2):351-8.
Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma - Prognostic features and natural history. American Journal of Clinical Oncology-Cancer Clinical Trials. 1999 Feb;22(1):22-8.
Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. International Journal of Radiation Oncology Biology Physics. 1999 Jul 15;44(5):1005-15.
Langer CJ. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Seminars in Radiation Oncology. 1999 Apr;9(2):108-16.
Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Gemcitabine and carboplatin in combination: An update of phase I and phase II studies in non-small cell lung cancer. Seminars in Oncology. 1999 Feb;26(1):12-8.
Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: A potential role for growth factor as mucosal protectant. Cancer Investigation. 1999 Jan;17(1):1-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term chemotherapy

chemotherapy therapy cisplatin carcinoma cancer radiotherapy trial phase-ii intervention combination breast-cancer phase-ii trial therapy-oncology-group paclitaxel randomized trial cells adenocarcinoma chemoradiation radiation platinum i-131 local recurrence infusion mucosal toxicity irradiation recurrent ipsilateral breast tumor recurrence measurement fatigue reductase oral mucositis disturbance require outcome measures informed consent postoperative radiation tamoxifen gemcitabine gene-expression progression bone-marrow transplantation marrow transplantation platinum-resistant induction treatment time lumpectomy term follow-up therapies iiib antiferritin resistant amino-acid-sequence NQO1- bone- Patterns of Care Study erythropoietin stem-cell transplantation prolongation postoperative gene oncology acute promyelocytic leukemia 6-quinone conservative surgery and radiation cancer- paclitaxel-resistant family epithelial ovarian-cancer cdna sequence rheumatoid-arthritis taxol cyclophosphamide 5-fluorouracil fibrolamellar carboplatin benzo[a]pyrene- postoperative radiotherapy myelodysplastic syndrome oncology-group nursing GM-CSF concurrent dexamethasone metastatic radiation therapy weekly paclitaxel high-dose cancer-patients toxicity perceptions carcinogenesis clinical trial morbidity recovery benzene cancer treatment radiation-therapy conserving monoclonal-antibody NAD(P)H : quinone oxidoreductase 1 adjustment liver cervix cancer quality-of-life sensitizer preferences 2-chlorodeoxyadenosine nonsmall cell lung hyperfractionated radiation-therapy first remission lung cancer nad(p)h-menadione oxidoreductase breast cancer metaanalysis responsiveness diarrhea definitive irradiation pelvic frozen-section analysis high-dose cytarabine neck-cancer doxorubicin healthy-individuals menadione CHO cells arsenic trioxide adjuvant therapy 3-hour infusion 3 future community oncology adjuvant treatment calcium leucovorin gynecologic-oncology-group - mice esophagectomy instrumentation follow-up neutropenia hepatoma fluorouracil regimen granulocyte-macrophage colony-stimulating comparing total mastectomy adjuvant tumor pharmacokinetics radiation oncology clinical-trials carcinogenicity salvage therapy
Last updated on Thursday, June 04, 2020